The Cooper Companies, Inc. (COO) is well-poised for growth, backed by strong prospects in its CooperVision (CVI) and CooperSurgical (CSI) business segments. Acquisitions boost the company's portfolio and buoy optimism. However, unfavorable currency movements and rising costs continue to hurt revenues and margins, respectively. Shares of this Zacks Rank #2 (Buy) company have risen 16.6% year to date compared with the industry's 0.3% growth. The S&P 500 Index has gained 20.6% in the said time frame. The Coope ...